ArticleCancer science2011

The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer.

Miyun Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.